Anne Marciniak, MD, PhD
About Anne Marciniak, MD, PhD
Anne Marciniak, MD, PhD, serves as the Senior Director and Head of Market Access Europe at Aimmune Therapeutics. With extensive experience in health economics and market access, she has held senior positions at several pharmaceutical companies and has a strong academic background in medicine and economics.
Work at Aimmune Therapeutics
Currently, Anne Marciniak serves as the Senior Director and Head of Market Access Europe at Aimmune Therapeutics. In this role, she has been instrumental in leading evidence generation activities, which include Real World Evidence (RWE) and Quality of Life (QoL) studies. These initiatives support the company's market access strategies. She manages Health Technology Assessment (HTA) submissions across Europe, aiming to optimize market access for Aimmune's products. Additionally, she evaluates and implements various reimbursement routes to enhance access to AR101 in targeted countries.
Previous Experience in Health Economics
Prior to her current role, Anne Marciniak held several significant positions in health economics. She worked at Amgen UK as the Director and Evidence Lead for International Health Economics from 2006 to 2011. Following this, she served as the Senior Director, Specialty Care Lead for International Health Economics at Allergan from 2016 to 2017. Her experience also includes a tenure at Pfizer Ltd as the Director of Worldwide Outcomes Research from 1995 to 2006, and at Daiichi Sankyo Europe GmbH as the Executive Director, Head of HEOR & PRA from 2012 to 2014.
Education and Expertise
Anne Marciniak has an extensive educational background in medicine and health economics. She earned her MD in Public Health from Universite de Grenoble, where she studied from 1979 to 1989. She furthered her studies in healthcare economics, obtaining an MSc from the University of York in 1992. Marciniak also pursued a PhD in Economics and Health Psychology at Brunel University, completing her studies in 2016. Additionally, she studied Epidemiology at Universite de Paris, achieving an MPhil (DEA) in 1990.
Stakeholder Engagement and Market Access Strategies
In her current role, Anne Marciniak has developed a comprehensive stakeholder engagement plan for AR101 across multiple European countries. She leads the development of aligned value stories tailored for payer stakeholders, ensuring that the messaging resonates with various audiences. Her focus on stakeholder engagement is essential for facilitating market access and ensuring that the company's products meet the needs of healthcare systems in Europe.